BDBM350535 2-(4,4-diethyl-2,5-dioxoimidazolidin- 1-yl)-N-(4-fluorophenyl)acetamide::US10208071, Table 3.11::US10799518, Structure TABLE 3.11

SMILES CCC1(CC)NC(=O)N(CC(=O)Nc2ccc(F)cc2)C1=O

InChI Key InChIKey=SBUMMNCNWGVRLJ-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 350535   

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350535(2-(4,4-diethyl-2,5-dioxoimidazolidin- 1-yl)-N-(4-f...)
Affinity DataEC50:  2.77E+6nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350535(2-(4,4-diethyl-2,5-dioxoimidazolidin- 1-yl)-N-(4-f...)
Affinity DataEC50:  2.77E+3nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent